Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/atsi) has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of ATS Medical, Inc. (“ATS Medical” or the “Company”) (NASDAQ: ATSI) in connection with their actions in causing ATS Medical to enter into a merger agreement with Medtronic, Inc.

Our investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by Company’s board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of ATS Medical. For more information regarding our investigation please contact Richard A. Maniskas, Esquire toll-free: (877) 316-3218 or visit: www.rmclasslaw.com/cases/atsi.

Under the terms of the transaction, ATS Medical shareholders will receive $4.00 in cash for each share of ATS they own.

If you own shares of ATS Medical and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free: (877) 316-3218 or visit: www.rmclasslaw.com/cases/atsi. You may also email Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.

Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan and Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.

Grafico Azioni Ats Medical (MM) (NASDAQ:ATSI)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Ats Medical (MM)
Grafico Azioni Ats Medical (MM) (NASDAQ:ATSI)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Ats Medical (MM)